Scientific Session
Metabolic bone disease
Stuart Ralston, MD, FRCP, MBChB
University of Edinburgh
Western General Hospital, Edinburgh, United Kingdom
Disclosure(s): AstraZeneca: Grant/Research Support (Terminated, April 30, 2023); Eli Lilly: Donation of IMP for clinical trial (Ongoing); Kyowa Kirin: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Donation of IMP for clinical trial (Terminated, May 31, 2022); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 14, 2022), Support to attend scientific meeting (Terminated, September 14, 2022)